280 related articles for article (PubMed ID: 8692515)
1. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
2. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
3. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
[TBL] [Abstract][Full Text] [Related]
4. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
5. Postoperative extended-field irradiation in patients with pelvic and/or common iliac node metastases from cervical carcinoma stages IB to IIB.
Inoue T; Chihara T; Morita K
Gynecol Oncol; 1986 Oct; 25(2):234-43. PubMed ID: 3019844
[TBL] [Abstract][Full Text] [Related]
6. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy.
Sakuragi N; Satoh C; Takeda N; Hareyama H; Takeda M; Yamamoto R; Fujimoto T; Oikawa M; Fujino T; Fujimoto S
Cancer; 1999 Apr; 85(7):1547-54. PubMed ID: 10193945
[TBL] [Abstract][Full Text] [Related]
7. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
9. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
11. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.
Sedlis A; Bundy BN; Rotman MZ; Lentz SS; Muderspach LI; Zaino RJ
Gynecol Oncol; 1999 May; 73(2):177-83. PubMed ID: 10329031
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.
Inoue T; Okumura M
Cancer; 1984 Oct; 54(8):1714-9. PubMed ID: 6478409
[TBL] [Abstract][Full Text] [Related]
15. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report.
Perez CA; Camel HM; Kao MS; Hederman MA
Gynecol Oncol; 1987 Jun; 27(2):129-40. PubMed ID: 3570053
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases.
Tattersall MH; Ramirez C; Coppleson M
Gynecol Oncol; 1992 Aug; 46(2):176-81. PubMed ID: 1500019
[TBL] [Abstract][Full Text] [Related]
18. 5-year results of postoperative extended-field irradiation on 76 patients with nodal metastases from cervical carcinoma stages IB to IIIB.
Inoue T; Morita K
Cancer; 1988 May; 61(10):2009-14. PubMed ID: 3129178
[TBL] [Abstract][Full Text] [Related]
19. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix.
Fuller AF; Elliott N; Kosloff C; Hoskins WJ; Lewis JL
Gynecol Oncol; 1989 Apr; 33(1):34-9. PubMed ID: 2703164
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy.
Gerdin E; Cnattingius S; Johnson P; Pettersson B
Gynecol Oncol; 1994 Jun; 53(3):314-9. PubMed ID: 8206404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]